1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Hyperlipoproteinemia Type III: new trials by email Literature Review of Hyperlipoproteinemia Type III trials Research Report on Hyperlipoproteinemia Type III
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. torcetrapib/atorvastatin, atorvastatin, fenofibrate - Hyperlipoproteinemia Type III | Phase 3 | Terminated | Pfizer | 41 | 2005-03-01 | 2012-02-17 |
| Type III Dysbetalipoproteinemia Rosuvastatin, rosuvastatin, pravastatin - Hyperlipoproteinemia Type III | Phase 3 | Completed | AstraZeneca | 30 | 2005-02-01 | 2010-11-19 |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dyslipidemias (2) · Genetic Diseases, Inborn (2) · Hyperlipidemias (2) · Hyperlipoproteinemias (2) · Lipid Metabolism Disorders (2) · Lipid Metabolism, Inborn Errors (2) · Metabolic Diseases (2) · Metabolism, Inborn Errors (2) · Nutritional and Metabolic Diseases (2)
Atorvastatin (1) · Fenofibrate (1) · Pravastatin (1) · Rosuvastatin Calcium (1) · torcetrapib (1)
AstraZeneca (1) · Pfizer (1)
Canada (1) · Norway (1) · South Africa (1) · United States (1)